Purpose The aim of our meta-analysis was to compare the efficacy and safety of
radiofrequency ablation (RFA) versus surgical resection for patients with small …

Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer death worldwide. No
more than 30% of HCC patients are considered suitable for curative treatment because of …

Background This study compares survival rates, recurrence patterns, toxicity, and treatment
cost in patients with hepatocellular carcinoma (HCC) treated with either transarterial …

Methods A total of 1,451 consecutive patients (median, 55 years old; males, 79.0%; hepatitis
B virus-related, 79.3%) with good liver function (Child-Pugh class A) diagnosed with early …

Liver metastases occur in up to 60% of patients with colorectal cancer, and the control of
liver metastases is considered to be of primary importance because it is a critical factor in …

Despite the great efforts that have been achieved in breast cancer treatment, it remains a
significant cause of death in women and is a serious health problem. Treatment with …

Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related mortalities
worldwide. Patients with early-stage HCC are eligible for curative treatments, such as …

Hepatocellularcarcinoma (HCC) is one of the leading causes of cancer-related deaths in the
world. Radiofrequency ablation (RFA) is an effective method for treating tumors less than 5 …

Introduction Radiofrequency ablation and percutaneous ethanol injection are important
treatment modalities for hepatocellular carcinoma patients; Whether a combination treatment …

Radiofrequency ablation (RFA) is an effective minimally-invasive treatment used for a variety
of solid tumor cancers, including lung, breast, kidney, pancreatic, and liver. However …